4893 items matching your search terms.

Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice

Veness, MJ Morgan, GJ Palme, CE Gebski, V

Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients?

Veness, MJ Morgan, GJ Sathiyaseelan, Y Gebski, V

Merkel cell carcinoma: improved outcome with adjuvant radiotherapy

Veness, MJ Perera, L McCourt, J Shannon, J Hughes, TM Morgan, GJ Gebski, V

SIR-Spheres for the treatment of non-resectable liver tumours

Walleser, S. Allen, F. Higgins, A. Howard, K. Lord, S. The Medical Services Advisory Committee

Computed tomography colonography

Walleser, S Lord, S Griffiths, A Howard, K Higgins, A; for the Medical Services Advisory Committee

Brain natriuretic peptide: a predictor of cardiovascular outcome in the LIPID study

West, MJ; Blankenberg, S; Simes, RJ; Keech, A; Pollicino, C; Kirby, A; Tonkin, A

Brain natriuretic peptide predicts cardiovascular outcome in stable CHD patients: the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study. The LIPID investigators

West, MJ; Blankenberg, S; Simes, RJ; Pollicino, C; Kirby, A; Nestel, P; White, H; Tonkin, A

Increased augmentation of central blood pressure is associated with increases in carotid intima-media thickness in type 2 diabetic patients

Westerbacka, J Leinonen, E Salonen, JT Salonen, R Hiukka, A Yki-Jarvinen, H Taskinen, MR

Participation in the RACS sentinel node biopsy versus axillary clearance trial

Wetzig, NR Gill, PG Ung, O Collins, J Kollias, J Gillett, D Gebski, V Greig, C Ray, A Stockler, M for the RACS SNAC Group,

Detecting glaucoma using visually evoked potentials

Wilson, V Byth, K

Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes

Wong, CK; French, JK; Aylward, PE; Stewart, RA; Gao, W; Armstrong, PW; Van De Werf, FJ; Simes, RJ; Raffel, OC; Granger, CB; Califf, RM; White, HD; HERO-2 Trial Investigators,

Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg

Zalcberg, JR Verweij, J Casali, PG Le Cesne, A Reichardt, P Blay, JY Schlemmer, M Van Glabbeke, M Brown, M Judson, IR EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group; Australasian Gastro-Intestinal Trials Group,

Drug-eluting stents

Allen, F. Marinovich, L. Howard, K. Lord, S. The Medical Services Advisory Committee

Charting the course of clinical research: from an inspired past to a promising future

Armstrong, PW Kaul, P and the VIGOUR group,

Lessons learned from a clinical trial

Armstrong, PW; Newby, LK; Granger, CB; Lee, KL; Simes, RJ; Van de Werf, F; White, HD; Califf, RM; for the VIGOUR group,